Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes

AIDS Research and Human Retroviruses

Volumn 21, Issue 4, 2005, Pages 273-284

  Nair, Amrithraj ^a,b   Michael, Bindhu ^a,b   Hiraragi, Hajime ^a   Fernandez, Soledad ^a   Feuer, Gerold ^c   Boris Lawrie, Kathleen ^a,d   Lairmore, Michael ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LUCIFERASE; PROTEIN P300; UNCLASSIFIED DRUG; VIRUS ACCESORY PROTEIN P12; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION;

APOPTOSIS; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; JURKAT CELLS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 18244385495     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.273     Document Type: Article

References (61)

1. Bangham CR: HTLV-1 infections. J Clin Pathol 2000;53:581-586.
2. Bangham CR: The immune response to HTLV-I. Curr Opin Immunol 2000;12:397-402.
3. Hollsberg P: Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999;63:308-333.
4. Mortreux F, Gabet AS, and Wattel E: Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003;17:26-38.
5. Albrecht B and Lairmore MD: Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev 2002;66:396-406.
6. Derse D, Mikovits J, and Ruscetti F: X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997; 237:123-128.
7. Robek MD, Wong FH, and Ratner L: Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol 1998;72:4458-4462.
8. I reduces viral infectivity in vivo. Blood 1998; 91:4701-4707.
9. I is required for efficient viral infectivity in primary lymphocytes. J Virol 2000;74:9828-9835.
10. Franchini G: Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995;86:3619-3639.
11. Kim SJ, Ding W, Albrecht B, Green PL, and Lairmore MD: A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J Biol Chem 2003;278:15550-15557.
12. Mulloy JC, Crownley RW, Fullen J, Leonard WJ, and Franchini G: The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor β and γ chains and affects their expression on the cell surface. J Virol 1996;70:3599-3605.
13. I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 2001;98:823-829.
14. I: Association with calreticulin and calnexin. J Virol 2001;75:7672-7682.
15. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 1993;67:2360-2366.
16. I expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J Virol 2002;76:10374-10382.
17. I. J Virol 2002;76:3493-3501.
18. De La Fuente C, Deng L, Santiago F, Arce L, Wang L, and Kashanchi F: Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses 2000;16:1695-1700.
19. Harhaj EW, Good LF, Xiao GT, and Sun SC: Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 1999;18:1341-1349.
20. Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, and Brady JN: Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 2002;62:3562-3571.
21. Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, and Zeichner SL: Genome-wide expression changes induced by HTLV-1 Tax: Evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation. Oncogene 2001;20:4484-4496.
22. Tsukasaki K, Tanosaki S, De Vos S, Hofmann WK, Wachsman W, Gombart AF, Krebs J, Jauch A, Bartram CR, Nagai K, Tomonaga M, Said JW, and Koeffler HP: Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. Int J Cancer 2004;109:875-881.
23. Kohno T, Moriuchi R, Katamine S, Yamada Y, Tomonaga M, and Matsuyama T: Identification of genes associated with the progression of adult T cell leukemia (ATL). Jpn J Cancer Res 2000;91:1103-1110.
24. + cells in vitro. J Virol 2003;77:12152-12164.
25. I enhances interleukin-2 production during T-cell activation. J Virol 2003;77:11027-11039.
26. II functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol 2000;74:11270-11277.
27. II regulates gene transcription by binding CREB binding protein/p300. J Virol 2001;75:9885-9895.
28. Li C and Wong WH: Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31-36.
29. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G: Gene ontology: Tool for the unification of biology. Gene Ontology Consortium. Nat Genet 2000;25:25-29.
30. Albrecht B, Collins ND, Newbound GC, Ratner L, and Lairmore MD: Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. J Virol Methods 1998;75:123-140.
31. Murphy D: Gene expression studies using microarrays: Principles, problems, and prospects. Adv Physiol Educ 2002;26:256-270.
32. Feske S, Giltnane J, Dolmetsch R, Staudt LM, and Rao A: Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2001;2:316-324.
33. 2+ influx in Bcl-2-overexpressing cells. J Cell Biol 2000;148:857-862.
34. 2+ homeostasis by Bcl-2. J Biol Chem 1999;274:33267-33273.
35. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, and Brady JN: Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 2000;20:5077-5086.
36. Janknecht R: The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 2002;17:657-668.
37. Goodman RH and Smolik S: CBP/p300 in cell growth, transformation, and development. Genes Dev 2000;14:1553-1577.
38. Vo N and Goodman RH: CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 2001;276:13505-13508.
39. Lemasson I, Polakowski NJ, Laybourn PJ and Nyborg JK: Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J Biol Chem 2002;277:49459- 49465.
40. Yan JP, Garrus JE, Giebler HA, Stargell LA and Nyborg JK: Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J Mol Biol 1998;281:395-400.
41. Blobel GA: CBP and p300: Versatile coregulators with important roles in hematopoietic gene expression. J Leukoc Biol 2002;71:545-556.
42. Tchilian EZ and Beverley PC: CD45 in memory and disease. Arch Immunol Ther Exp (Warsz) 2002;50:85-93.
43. Moro H, Iwai K, Mori N, Watanabe M, Fukushi M, Oie M, Arai M, Tanaka Y, Miyawaki T, Gejyo F, Arakawa M, and Fujii M: Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo. Virus Genes 2001;23:263-271.
44. Bangham CR: Human T-lymphotropic virus type 1 (HTLV-1): Persistence and immune control. Int J Hematol 2003;78:297-303.
45. Johnson JM, Mulloy JC, Ciminale V, Fullen J, Nicot C, and Franchini G: The MHC class I heavy chain is a common target of the small proteins encoded by the 3′ end of HTLV type 1 and HTLV type 2. AIDS Res Hum Retroviruses 2000;16:1777-1781.
46. Johnson JM, Milloy JC, Ciminale V, et. al.: The MHC class I heavy chain is a common target of the small proteins encoded by 3′ end of HTLV type 1 and HTLV type 2. AIDS Res Hum Retroviruses 2000;16:1777-1786.
47. D'Souza-Schorey C, Li G, Colombo MI, and Stahl PD: A regulatory role for ARF6 in receptor-mediated endocytosis. Science 1995;267:1175-1178.
48. Garcia-Rodriguez C, and Rao A: Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med 1998;187:2031-2036.
49. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, and Nabel GJ: Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997;275:523-527.
50. Subbaramaiah K, Lin DT, Hart JC, and Dannenberg AJ: Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2: Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem 2001;276:12440-12448.
51. Wang L, Grossman SR, and Kieff E: Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci USA 2000;97:430-435.
52. Hottiger MO and Nabel GJ: Viral replication and the coactivators p300 and CBP. Trends Microbiol 2000;8:560-565.
53. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, Kong YY, Ohteki T, Shahinian A, Bachmann M, Ohashi PS, Penninger JM, Crabtree GR, and Mak TW: The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998;8:115-124.
54. Kinoshita S, Su L, Amano M, Timmerman LA, Kaneshima H, and Nolan GP: The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 1997;6:235-244.
55. Kinoshita S, Chen BK, Kaneshima H, and Nolan GP: Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 1998;95:595-604.
56. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, and Kelly K: Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1997;89:1175-1184.
57. Shikama N, Lyon J, and Lathangue NB: The p300/CBP family: Integrating signals with transcription factors and chromatin. Trends Cell Biol 1997;7:230-236.
58. Borrow J, Stanton VP, Andresen JM, Becher R, Behm FG, Chaganti RSK, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, and Housman DE: The translocation t(8;16)(p11 p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein. Nat Genet 1996;14:33-41.
59. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M, and Hayashi Y: Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 1997;90:4699-4704.
60. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, and Zeleznik L: MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 1997;94:8732-8737.
61. Collins ND, D'Souza C, Albrecht B, Robek MD, Ratner L, Ding W, Green PL, and Lairmore MD: Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. J Virol 1999;73:9642-9649.